Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesEndeavor Stent Reduced Risk of Heart Attack/Cardiac Death by 48% at Three Years Compared to Taxus Stent in Large Study
Medtronic, 09/22/09
Anticipating a change in the practice of interventional cardiology, Medtronic, Inc., announced that the latest findings from the ENDEAVOR IV clinical trial – a large study comparing two drug–eluting coronary stents head–to–head – demonstrate statistically and clinically significant differences in measures of safety between Medtronic's Endeavor zotarolimus–eluting stent and Boston Scientific's Taxus paclitaxel–eluting stent at three years of patient follow–up.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
New England Journal of Medicine, 11/20/09
Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
JAMA, 11/25/09
Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
Abbott, 11/16/09
Sponsor
Article Search
Sponsor